Diagnostic Value of IGF-1 in Growth Hormone-Deficient Children: Is a Second Growth Hormone Stimulation Test Necessary?

Overview

Journal J Endocr Soc

Specialty Endocrinology

Date 2023 Feb 27

PMID 36846213

Authors

Tarah H Fatani

Affiliations

Soon will be listed here.

Abstract

Objective: we assessed the diagnostic accuracy of insulin-like growth factor (IGF) 1 measurements with 1 growth hormone stimulation test (GHST) vs performing 2 GHSTs as the standard test to confirm the diagnosis of growth hormone deficiency (GHD) in children.

Methods: We retrospectively analyzed the baseline characteristics, anthropometric measurements, and laboratory data of 703 children with short stature, aged 4-14 years (mean age, 8.46 ± 2.7 years), who had undergone 2 GHSTs. We compared the diagnostic values of IGF-1 levels by using a cut-off value of ≤0 SD score, along with results of a single clonidine stimulation test (CST). We evaluated the false-positive rate, specificity, likelihood ratio, and area under the curve (AUC) of the 2 diagnostic methods. GHD was diagnosed if the peak growth hormone level was <7 ng/mL on 2 GHSTs.

Results: Of the 724 children, 577 (79.7%) had a low IGF-1 level (mean 104.9 ± 61.4 ng/mL), and 147 (20.3%) had a normal IGF-1 level (mean 145.9 ± 86.9 ng/mL). GHD was diagnosed in 187 patients (25.8%), of whom 146 (25.3%) had a low IGF-1 level. An IGF-1 level reflecting ≤0 SDs in combination with results of a single CST had a specificity of 92.6%, a false-positive rate of 5.5%, and an AUC of 0.6088. Using an IFG-1 cut-off level of ≤-2 SDs did not alter the diagnostic accuracy.

Conclusion: Low IGF-1 values of ≤0 SDs or ≤-2 SDs in combination with results of a single CST had poor diagnostic accuracy for GHD.

Citing Articles

Clinical and laboratory characteristics but not response to treatment can distinguish children with definite growth hormone deficiency from short stature unresponsive to stimulation tests.

Lanzetta M, Dalla Bona E, Tamaro G, Vidonis V, Vittori G, Faleschini E Front Endocrinol (Lausanne). 2024; 15:1288497.

PMID: 38495788 PMC: 10940512. DOI: 10.3389/fendo.2024.1288497.

Idiopathic isolated adrenocorticotropic hormone deficiency: a systematic review of a heterogeneous and underreported disease.

Van Mieghem E, De Block C, De Herdt C Pituitary. 2023; 27(1):23-32.

PMID: 38151529 DOI: 10.1007/s11102-023-01366-9.

References

Inoue-Lima T, Vasques G, Scalco R, Nakaguma M, Mendonca B, Arnhold I . IGF-1 assessed by pubertal status has the best positive predictive power for GH deficiency diagnosis in peripubertal children. J Pediatr Endocrinol Metab. 2019; 32(2):173-179. DOI: 10.1515/jpem-2018-0435. View

Al Herbish A, Almutair A, Bin Abbas B, Alsagheir A, Alqahtani M, Kaplan W . Diagnosis and management of growth disorders in Gulf Cooperation Council (GCC) countries: Current procedures and key recommendations for best practice. Int J Pediatr Adolesc Med. 2019; 3(3):91-102. PMC: 6372455. DOI: 10.1016/j.ijpam.2016.07.002. View

Cianfarani S, Tondinelli T, Spadoni G, Scire G, Boemi S, Boscherini B . Height velocity and IGF-I assessment in the diagnosis of childhood onset GH insufficiency: do we still need a second GH stimulation test?. Clin Endocrinol (Oxf). 2002; 57(2):161-7. DOI: 10.1046/j.1365-2265.2002.01591.x. View

Marshall W, Tanner J . Variations in pattern of pubertal changes in girls. Arch Dis Child. 1969; 44(235):291-303. PMC: 2020314. DOI: 10.1136/adc.44.235.291. View

Wit J, Bidlingmaier M, de Bruin C, Oostdijk W . A Proposal for the Interpretation of Serum IGF-I Concentration as Part of Laboratory Screening in Children with Growth Failure. J Clin Res Pediatr Endocrinol. 2019; 12(2):130-139. PMC: 7291410. DOI: 10.4274/jcrpe.galenos.2019.2019.0176. View

Marshall W, Tanner J . Variations in the pattern of pubertal changes in boys. Arch Dis Child. 1970; 45(239):13-23. PMC: 2020414. DOI: 10.1136/adc.45.239.13. View

Ali A, Hashim R, Khan F, Sattar A, Ijaz A, Manzoor S . Evaluation of insulin-like growth factor-1 and insulinlike growth factor binding protein-3 in diagnosis of growth hormone deficiency in short-stature children. J Ayub Med Coll Abbottabad. 2010; 21(3):40-5. View

Chinoy A, Murray P . Diagnosis of growth hormone deficiency in the paediatric and transitional age. Best Pract Res Clin Endocrinol Metab. 2016; 30(6):737-747. DOI: 10.1016/j.beem.2016.11.002. View

Laron Z . Insulin-like growth factor 1 (IGF-1): a growth hormone. Mol Pathol. 2001; 54(5):311-6. PMC: 1187088. DOI: 10.1136/mp.54.5.311. View

10.

Codner E, Mericq V, UGARTE F, Iniguez G, Espinoza M, Avila A . [Usefulness of the measurement of insulin-like growth factor (IGF-I) and IGF-1 binding protein-3 (IGFBP-3) for the diagnosis of growth hormone (GH) deficiency in children]. Rev Med Chil. 2000; 127(7):807-13. View

11.

Cianfarani S, Liguori A, Germani D . IGF-I and IGFBP-3 assessment in the management of childhood onset growth hormone deficiency. Endocr Dev. 2005; 9:66-75. DOI: 10.1159/000085757. View

12.

Collett-Solberg P, Ambler G, Backeljauw P, Bidlingmaier M, Biller B, Boguszewski M . Diagnosis, Genetics, and Therapy of Short Stature in Children: A Growth Hormone Research Society International Perspective. Horm Res Paediatr. 2019; 92(1):1-14. PMC: 6979443. DOI: 10.1159/000502231. View

13.

Blum W, Alherbish A, Alsagheir A, El Awwa A, Kaplan W, Koledova E . The growth hormone-insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders. Endocr Connect. 2018; 7(6):R212-R222. PMC: 5987361. DOI: 10.1530/EC-18-0099. View

14.

Guzzetti C, Ibba A, Pilia S, Beltrami N, Di Iorgi N, Rollo A . Cut-off limits of the peak GH response to stimulation tests for the diagnosis of GH deficiency in children and adolescents: study in patients with organic GHD. Eur J Endocrinol. 2016; 175(1):41-7. DOI: 10.1530/EJE-16-0105. View

15.

Zelazowska-Rutkowska B, Trusiak M, Bossowski A, Cylwik B . Diagnostic Usefulness of Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor Binding Protein 3 in Children with Suspected Pituitary Dwarfism. Clin Lab. 2018; 64(5):759-765. DOI: 10.7754/Clin.Lab.2018.171126. View

16.

Bussieres L, Souberbielle J, Pinto G, Adan L, Noel M, Brauner R . The use of insulin-like growth factor 1 reference values for the diagnosis of growth hormone deficiency in prepubertal children. Clin Endocrinol (Oxf). 2000; 52(6):735-9. DOI: 10.1046/j.1365-2265.2000.00999.x. View

17.

Rosenfeld R, Albertsson-Wikland K, Cassorla F, FRASIER S, Hasegawa Y, Hintz R . Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab. 1995; 80(5):1532-40. DOI: 10.1210/jcem.80.5.7538145. View

18.

Ibba A, Loche S . Diagnosis of GH Deficiency Without GH Stimulation Tests. Front Endocrinol (Lausanne). 2022; 13:853290. PMC: 8894314. DOI: 10.3389/fendo.2022.853290. View

19.

Federico G, Street M, Maghnie M, Caruso-Nicoletti M, Loche S, Bertelloni S . Assessment of serum IGF-I concentrations in the diagnosis of isolated childhood-onset GH deficiency: a proposal of the Italian Society for Pediatric Endocrinology and Diabetes (SIEDP/ISPED). J Endocrinol Invest. 2006; 29(8):732-7. DOI: 10.1007/BF03344184. View

20.

Clemmons D . Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clin Chem. 2011; 57(4):555-9. DOI: 10.1373/clinchem.2010.150631. View